| Product Code: ETC13332853 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Medical Cannabis Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Medical Cannabis Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Medical Cannabis Market Revenues & Volume, 2021 & 2031F |
3.3 North America Medical Cannabis Market - Industry Life Cycle |
3.4 North America Medical Cannabis Market - Porter's Five Forces |
3.5 North America Medical Cannabis Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Medical Cannabis Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.7 North America Medical Cannabis Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
3.8 North America Medical Cannabis Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 North America Medical Cannabis Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 North America Medical Cannabis Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Medical Cannabis Market Trends |
6 North America Medical Cannabis Market, 2021 - 2031 |
6.1 North America Medical Cannabis Market, Revenues & Volume, By Product Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Medical Cannabis Market, Revenues & Volume, By Oils and Tinctures, 2021 - 2031 |
6.1.3 North America Medical Cannabis Market, Revenues & Volume, By Edibles, 2021 - 2031 |
6.1.4 North America Medical Cannabis Market, Revenues & Volume, By Topicals, 2021 - 2031 |
6.2 North America Medical Cannabis Market, Revenues & Volume, By Application Area, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Medical Cannabis Market, Revenues & Volume, By Pain Management, 2021 - 2031 |
6.2.3 North America Medical Cannabis Market, Revenues & Volume, By Neurological Disorders, 2021 - 2031 |
6.2.4 North America Medical Cannabis Market, Revenues & Volume, By Mental Health Disorders, 2021 - 2031 |
6.3 North America Medical Cannabis Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Medical Cannabis Market, Revenues & Volume, By Patients with Chronic Conditions, 2021 - 2031 |
6.3.3 North America Medical Cannabis Market, Revenues & Volume, By Cancer Patients, 2021 - 2031 |
6.3.4 North America Medical Cannabis Market, Revenues & Volume, By Individuals with Anxiety, 2021 - 2031 |
6.4 North America Medical Cannabis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.4.2 North America Medical Cannabis Market, Revenues & Volume, By Dispensaries, 2021 - 2031 |
6.4.3 North America Medical Cannabis Market, Revenues & Volume, By Online Platforms, 2021 - 2031 |
6.4.4 North America Medical Cannabis Market, Revenues & Volume, By Pharmacies, 2020 - 2028 |
7 North America Medical Cannabis Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Medical Cannabis Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.1 United States (US) Medical Cannabis Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.2 Canada Medical Cannabis Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.2.3 Rest of North America Medical Cannabis Market, Revenues & Volume, By Product Type, 2021 - 2031 |
7.3 North America Medical Cannabis Market Revenues & Volume Share, By Application Area, 2021 & 2031F |
7.3.1 United States (US) Medical Cannabis Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.2 Canada Medical Cannabis Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.3.3 Rest of North America Medical Cannabis Market, Revenues & Volume, By Application Area, 2021 - 2031 |
7.4 North America Medical Cannabis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.1 United States (US) Medical Cannabis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.2 Canada Medical Cannabis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.4.3 Rest of North America Medical Cannabis Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5 North America Medical Cannabis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.1 United States (US) Medical Cannabis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.2 Canada Medical Cannabis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
7.5.3 Rest of North America Medical Cannabis Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 North America Medical Cannabis Market Key Performance Indicators |
9 North America Medical Cannabis Market - Export/Import By Countries Assessment |
10 North America Medical Cannabis Market - Opportunity Assessment |
10.1 North America Medical Cannabis Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Medical Cannabis Market Opportunity Assessment, By Product Type, 2021 & 2031F |
10.3 North America Medical Cannabis Market Opportunity Assessment, By Application Area, 2021 & 2031F |
10.4 North America Medical Cannabis Market Opportunity Assessment, By End User, 2021 & 2031F |
10.5 North America Medical Cannabis Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
11 North America Medical Cannabis Market - Competitive Landscape |
11.1 North America Medical Cannabis Market Revenue Share, By Companies, 2022 |
11.2 North America Medical Cannabis Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here